Contextual Effects on Inflammatory Biomarkers and Pain Relief After Spinal Joint Manipulation
Recruiting now · Not applicable
Conditions studied: Low Back Pain
In brief
The goal of this clinical trial is to learn whether contextual effects created by observational learning can change pain relief and inflammation-related biological responses after spinal joint manipulation in adults with chronic non-specific low back pain. The main questions it aims to answer are: Does positive, neutral, or negative observational learning change pain after spinal joint manipulation? Does it change disability, lumbar range of motion, stress, fear of movement, empathy, and treatment expectations? Does it change pressure pain threshold, lumbar tissue temperature, and blood markers related to inflammation, including interleukin-6 (IL-6), high-sensitivity C-reactive protein (hs-CRP), tumor necrosis factor alpha (TNF-α), and interleukin-10 (IL-10)? The researchers will compare 3 groups: a positive expectation group, a neutral group, and a negative expectation group. Before the treatment, each participant will have a short interaction with a trained simulated patient. The simulated patient will present a positive, neutral, or negative experience with spinal manipulation, depending on group assignment. After this, all the participants will receive the same spinal joint manipulation procedure. The participants will: * be randomly assigned to 1 of 3 study groups, * complete baseline questionnaires and clinical tests before treatment, * take part in a brief observational learning session before manipulation, * receive 1 spinal joint manipulation treatment, * complete outcome measurements before treatment, about 60 minutes after treatment, and 24 hours after treatment, * provide blood samples for analysis of inflammation-related biomarkers. This study will include adults aged 18 to 65 years with chronic non-specific low back pain. The main outcome is pain intensity. Secondary outcomes include disability, stress, empathy, fear of movement, lumbar range of motion, tissue temperature, pressure pain threshold, and treatment expectations. Exploratory outcomes include blood biomarkers related to inflammation.
Key facts
- Study ID
- NCT07507604
- Run by
- John Paul II University in Biała Podlaska
- People needed
- 73
- Starts
- 2026-04-21
- Expected to finish
- 2026-09-30
- Last updated by the study team
- 2026-06-03
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- people with low back pain lasting longer than 3 months, aged 18 to 65 years,
- highest reported pain intensity during the last 24 hours of at least 4 out of 10 on the 11-point Numeric Pain Rating Scale (NPRS-11), where 0 = no pain and 10 = worst imaginable pain,
- clinical diagnosis of chronic non-specific low back pain (NSCLBP) based on symptoms located in the lumbar spine region and not on imaging findings,
- no use of nonsteroidal anti-inflammatory drugs (NSAIDs) for at least 7 days before the study,
- no use of pain medication for at least 24 hours before the study,
- no use of corticosteroids,
- no previous spinal manipulation therapy,
- no alcohol, nicotine, or coffee consumption for at least 12 hours before the study,
- written informed consent to participate in the study.
You may not qualify if…
- physiotherapy students,
- presence of red flags, such as a history of cancer, constant or non-mechanical pain, progressive or radiating pain, sensory deficits in the trunk or - lower limbs, lower limb muscle weakness, or bladder/bowel dysfunction,
- body mass index (BMI) greater than 30,
- previous lumbar spine surgery,
- lumbar spine injury within 6 months before the study,
- diagnosed diabetes,
- diagnosed rheumatic diseases,
- affective disorders such as post-traumatic stress disorder (PTSD) or schizophrenia,
- spondylolisthesis or spondylolysis confirmed by imaging,
- diagnosed endometriosis,
- use of hormonal medications,
- sleep disorders,
- shift work,
- musculoskeletal injury within the last 14 days,
- active infection,
- pregnancy,
- endocrine disorders such as hyperthyroidism or hypothyroidism,
- use of opioid medications, including over-the-counter combination products such as codeine with paracetamol,
- current or recent use of antidepressants affecting serotonin or dopamine (including SSRIs, SNRIs, tricyclic antidepressants, MAO inhibitors, or ketamine),
- current diagnosis of major depressive disorder or bipolar disorder, as well as PTSD or schizophrenia,
- ongoing psychotherapy during the study period,
- cognitive impairment or significant hearing impairment that may interfere with understanding or processing the observational learning procedure.
Where it is running
- John Paul II University in Biała Podlaska — Biała Podlaska, Lublin Voivodeship, Poland (enrolling)
- Laboratory of the John Paul II University in Biała Podlaska — Biała Podlaska, Lublin Voivodeship, Poland (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.